(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Oncología > Oncología molecular > DA - CIMA - Oncología - Oncología molecular - Artículos de Revista >

Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes
Autor(es) : Rubio-Moscardo, F. (Fanny)
Blesa, D. (David)
Mestre-Escorihuela, C. (Cinta)
Siebert, R. (Reiner)
Balasas, T. (T.)
Benito, A. (Alberto)
Rosenwald, A. (Andreas)
Climent, J. (J.)
Martinez, J.I. (José I.)
Schilhabel, M. (Markus)
Karran, E.L. (E. L.)
Gesk, S. (Stefan)
Esteller, M. (Manel)
DeLeeuw, R. (R.)
Staudt, L.M. (Louis M.)
Fernandez-Luna, J.L. (J.L.)
Pinkel, D. (Daniel)
Dyer, M.J.S. (Martin J. S.)
Martinez-Climent, J.A. (José Ángel)
Palabras clave : Lymphoma, B-Cell
Genes, Tumor Suppressor
Fecha incorporación: 2005
Editorial : American Society of Hematology
Versión del editor: http://bloodjournal.hematologylibrary.org/content/106/9/3214
ISSN: 1528-0020
Cita: Rubio-Moscardo F, Blesa D, Mestre C, Siebert R, Balasas T, Benito A, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood 2005 Nov 1;106(9):3214-3222
Resumen
Deletions of chromosome 8p are a recurrent event in B-cell non-Hodgkin lymphoma (B-NHL), suggesting the presence of a tumor suppressor gene. We have characterized these deletions using comparative genomic hybridization to microarrays, fluorescence in situ hybridization (FISH) mapping, DNA sequencing, and functional studies. A minimal deleted region (MDR) of 600 kb was defined in chromosome 8p21.3, with one mantle cell lymphoma cell line (Z138) exhibiting monoallelic deletion of 650 kb. The MDR extended from bacterial artificial chromosome (BAC) clones RP11-382J24 and RP11-109B10 and included the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor gene loci. Sequence analysis of the individual expressed genes within the MDR and DNA sequencing of the entire MDR in Z138 did not reveal any mutation. Gene expression analysis and quantitative reverse transcriptase-polymerase chain reaction (QRT-PCR) showed down-regulation of TRAIL-R1 and TRAIL-R2 receptor genes as a consistent event in B-NHL with 8p21.3 loss. Epigenetic inactivation was excluded via promoter methylation analysis. In vitro studies showed that TRAIL-induced apoptosis was dependent on TRAIL-R1 and/or -R2 dosage in most tumors. Resistance to apoptosis of cell lines with 8p21.3 deletion was reversed by restoration of TRAIL-R1 or TRAIL-R2 expression by gene transfection. Our data suggest that TRAIL-R1 and TRAIL-R2 act as dosage-dependent tumor suppressor genes whose monoallelic deletion can impair TRAIL-induced apoptosis in B-cell lymphoma.
Enlace permanente: http://hdl.handle.net/10171/17901
Aparece en las colecciones: DA - CIMA - Oncología - Oncología molecular - Artículos de Revista

Ficheros en este registro:
Fichero:  3214.full.pdf
Descripción: 
Tamaño:  654,65 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.